EP 2675462 A2 20131225 - SULPHATED ARABINOGALACTANS, APIOGALACTURONANS AND SULPHATED HETEROGLYCANS FOR TREATING DISEASES CAUSED BY THE INFLUENZA VIRUS
Title (en)
SULPHATED ARABINOGALACTANS, APIOGALACTURONANS AND SULPHATED HETEROGLYCANS FOR TREATING DISEASES CAUSED BY THE INFLUENZA VIRUS
Title (de)
SULFATIERTE ARABINOGALAKTANE, APIOGALAKTURONANE UND SULFATIERTE HETEROGLYKANE ZUR BEHANDLUNG VON DURCH DAS GRIPPEVIRUS VERURSACHTEN ERKRANKUNGEN
Title (fr)
ARABINOGALACTANES SULFATES, APIOGALACTURONANES ET HETEROGLYCANES SULFATES POUR LE TRAITEMENT DES MALADIES CAUSEES PAR LES VIRUS INFLUENZA
Publication
Application
Priority
- FR 1150049 A 20110104
- FR 2012050017 W 20120103
Abstract (en)
[origin: WO2012093234A2] The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical composition including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans; an extract of Zostera marina or Lemna minor, including apiogalacturonans; or an extract of Caulerpa racemosa, including sulphated heteroglycans.
IPC 8 full level
A61P 31/16 (2006.01); A23L 33/00 (2016.01); A61K 31/715 (2006.01)
CPC (source: EP US)
A61K 31/715 (2013.01 - EP US); A61K 31/737 (2013.01 - EP US); A61K 36/05 (2013.01 - EP US); A61K 36/888 (2013.01 - EP US); A61P 31/12 (2017.12 - EP); A61P 31/16 (2017.12 - EP)
Citation (search report)
See references of WO 2012093234A2
Citation (examination)
- GOELLNER ESTHER MARIE ET AL: "Structure of arabinogalactan from Larix laricina and its reactivity with antibodies directed against type-II-arabinogalactans", CARBOHYDRATE POLYMERS, vol. 86, no. 4, October 2011 (2011-10-01), pages 1739 - 1744, XP028270250, DOI: 10.1016/J.CARBPOL.2011.07.006
- CHEN MEI-ZHEN ET AL: "In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis", VIROLOGICA SINICA OCT 2010, vol. 25, no. 5, October 2010 (2010-10-01), pages 341 - 351, XP055455088, ISSN: 1995-820X, DOI: doi:10.1007/s12250-010-3137-x
- ZHENG W ET AL: "Oral administration of exopolysaccharide from Aphanothece halophytica (Chroococcales) significantly inhibits influenza virus (H1N1)-induced pneumonia in mice", INTERNATIONAL IMMUNOPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 7, 1 July 2006 (2006-07-01), pages 1093 - 1099, XP024976865, ISSN: 1567-5769, [retrieved on 20060701], DOI: 10.1016/J.INTIMP.2006.01.020
- DROZD N N ET AL: "[Anticoagulant activity of arabinogalactane sulfate and cedar bark extract studied in vitro]", EKSPERIMENTAL'NAIA I KLINICHESKAIA FARMAKOLOGIIA, vol. 71, no. 4, July 2008 (2008-07-01), pages 30 - 34, ISSN: 0869-2092
- ANDERSON N. S. ET AL.: "Carrageenans. Part 1V.l Variations in the Structure and Gel Properties of kappa-Carrageenan, and the Characterisation of Sulphate Esters by lnfrared Spectroscopy", JOURNAL OF THE CHEMICAL SOCIETY C: ORGANIC, 1968, pages 602 - 606, DOI: 10.1039/J39680000602
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
FR 2969926 A1 20120706; FR 2969926 B1 20170310; BR 112013017178 A2 20161004; CN 103476418 A 20131225; CN 103476418 B 20170714; EP 2675462 A2 20131225; US 2014023675 A1 20140123; US 9011939 B2 20150421; WO 2012093234 A2 20120712; WO 2012093234 A3 20120913
DOCDB simple family (application)
FR 1150049 A 20110104; BR 112013017178 A 20120103; CN 201280011695 A 20120103; EP 12702582 A 20120103; FR 2012050017 W 20120103; US 201213977780 A 20120103